Amedisys is expected to merge with Option Care Health in the second half of 2023. The deal, which valued the former at $3.6 billion, was announced at the beginning of May.
The shareholders of each company still have to approve the deal.
Meanwhile, the two companies released a bevy of supportive analyst notes from a wide array of organizations. The document, dubbed “support for the merger,” was posted to the companies’ shared website, Home Health Care News reports.
“We see the long-term value of gaining more scale with payers and referral sources,” Bank of America wrote in its analysis. “Given the scale, we believe the combined businesses could grow faster than each company separately as they gain market share and are better positioned to participate in value-based care compared to their smaller peers.” Read more.
